Real-time enrollment status for this fallopian tube endometrioid adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:18 PM UTC
| NCT Number | NCT05415709 |
| Recruiting Status | Recruiting |
| Condition | Fallopian Tube Endometrioid Adenocarcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 45 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Ohio State University Comprehensive Cancer Center |
| Last Updated on CT.gov | February 11, 2026 (Feb 11, 2026) |
As of July 13, 2026: Clinical trial NCT05415709 is currently recruiting participants. This clinical trial study for fallopian tube endometrioid adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Ohio State University Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05415709 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05415709 was last updated Feb 11, 2026 (February 11, 2026). HelloStudys verifies this status automatically.